Ayr's Second Act: Creditors Take Control in Major Cannabis Restructuring

MIAMI, FL – June 02, 2026 – The name on the dispensaries may remain the same, but the ownership, balance sheet, and future of Ayr Wellness have been irrevocably altered. In a landmark move for the distressed cannabis sector, AYR Wellness Inc. announced today the transfer of its prized operations in Florida, New Jersey, and Nevada to Arboretum Bidco LLC, an entity created and controlled by the company’s senior secured noteholders.

This transaction is not a merger or a simple sale; it is the pivotal moment in a complex, court-supervised restructuring that sees the old Canadian parent company march toward liquidation while its valuable U.S. assets are salvaged by its primary lenders. For an industry built on high-risk growth, the Ayr saga provides a sobering blueprint for what happens when debt comes due and market realities set in. It’s a transition from shareholder control to creditor stewardship, marking a new era of financial discipline for a brand that expanded rapidly on borrowed capital.

From C-Suite to Creditor Control

The groundwork for today’s announcement was laid months ago. On November 17, 2025, AYR Wellness Inc., the Canadian parent entity, sought protection under the Companies' Creditors Arrangement Act (CCAA) in the Supreme Court of British Columbia. This legal maneuver was the culmination of a period of intense financial pressure, with the company deemed "over-leveraged and facing ongoing industry, regulatory, and management challenges," according to court filings.

By March 31, 2025, its consolidated balance sheet showed a staggering $946 million in total liabilities against a backdrop of market saturation, persistent federal regulatory hurdles, and crushing tax burdens under IRS code 280E. The CCAA filing was a strategic decision to insulate the U.S. operational subsidiaries—which were not part of the insolvency proceedings—while allowing for an orderly wind-down of the Canadian corporate shell under the supervision of monitor KSV Restructuring Inc.

The core of the rescue plan is the Master Purchase Agreement, dated November 14, 2025. This agreement designated Arboretum Bidco LLC—a vehicle established by senior noteholders led by Boston-based Millstreet Capital Management—as the purchaser of AYR’s most strategic assets. In essence, the lenders are converting their debt into ownership, a move one analyst called a "draconian solution" that effectively wipes out the value of the original publicly traded equity.

Building the New Ayr on a Foundation of Debt

Arboretum's mission is to resurrect the "Ayr Wellness" brand on a much sounder financial footing. The restructuring is engineered to slash the company's crippling debt load by more than 50%. The new entity is not starting from scratch; it's being capitalized with a new $275 million senior secured delayed draw Exit Facility, backstopped by Millstreet Capital, designed to fund operations and future growth.

This new capital structure is telling. The five-year facility carries a 13% annual interest rate, but with a crucial payment-in-kind (PIK) option for the first 24 months, allowing the new company to preserve cash as it stabilizes. It's a clear signal that the new owners understand the long, cash-intensive road ahead. Scott Davido, who is expected to become the Interim CEO of the new Arboretum-led company, has previously expressed confidence that the support from lenders who "get the industry and believe in what we're building" will pave the way for sustainable growth.

The strategy is one of continuity in operations but revolution in finance. By taking control, the noteholders are betting they can succeed where the previous management struggled, unburdened by the legacy debt that choked the company's cash flow and strategic flexibility. This includes a commitment of an additional $50 million to support growth, particularly in promising markets like Virginia, where the first asset transfer to Arboretum occurred on April 10, 2026.

A Bellwether for a Bruised Industry

AYR Wellness's story is a microcosm of the immense challenges facing U.S. multi-state cannabis operators (MSOs). The initial green rush saw companies take on massive debt to fund aggressive, state-by-state expansion, often paying premium prices for licenses and assets. The expectation was that federal legalization or, at minimum, banking reform was just around the corner, which would unlock traditional capital markets and normalize operating conditions.

That optimism has since collided with reality. The slow pace of federal reform has left companies stranded in a state-by-state patchwork of regulations, unable to move products or cash across state lines and barred from accessing standard banking services. The 280E tax code prevents them from deducting normal business expenses, forcing them to pay sky-high effective tax rates that can exceed 70%.

This environment has created a capital-starved industry where the only available financing often comes from high-interest private debt. AYR's restructuring is a powerful illustration of the end-game in this scenario: when growth stalls and debt maturities loom, the lenders who provided the lifeline are the ones who ultimately take the keys. This trend is likely to accelerate, leading to further consolidation as distressed operators are absorbed by better-capitalized competitors or, as in this case, by their own creditors.

The View From the Ground

For customers walking into an Ayr Wellness dispensary in Miami, Las Vegas, or Woodbridge, New Jersey, the change in ownership may not be immediately apparent. Arboretum's stated intention to operate under the same trade name suggests a desire to maintain brand recognition and consumer loyalty. However, behind the scenes, the transfer of control over operations in these key states—along with Virginia and, eventually, Ohio, Massachusetts, and Pennsylvania—represents a fundamental shift.

The immediate focus will be on operational efficiency and profitability. While this could lead to a more streamlined and stable business, it also raises questions about the local impact. Decisions driven by a Boston-based investment adviser may differ from those of the previous management. The fate of employees, local marketing initiatives, and product assortments now rests with a leadership team whose primary mandate is financial recovery.

Furthermore, uncertainty lingers for the assets not explicitly included in the primary transfer to Arboretum, such as those in Illinois and Connecticut. Their future will be determined as part of the parent company's broader liquidation, a stark reminder that even in a restructuring designed to save the core, some pieces may be deemed non-essential and sold off or wound down. The rebirth of Ayr Wellness under new stewardship is a story of survival, but it is also a cautionary tale about the hidden costs of ambition in the chaotic world of American cannabis.